当前位置: 首页 >> 检索结果
8081. Antibodies against oxidized low-density lipoproteins in systemic sclerosis.
作者: A L Herrick.;K J Illingworth.;S Hollis.;J M Gomez-Zumaquero.;F J Tinahones.
来源: Rheumatology (Oxford). 2001年40卷4期401-5页
To investigate whether circulating concentrations of antibodies against oxidized low-density lipoproteins (LDL) are increased in patients with systemic sclerosis (SSc).
8082. Interleukin-6 promoter polymorphism (--174 G/C) in Caucasian German patients with systemic lupus erythematosus.
作者: H Schotte.;B Schlüter.;S Rust.;G Assmann.;W Domschke.;M Gaubitz.
来源: Rheumatology (Oxford). 2001年40卷4期393-400页
A biallelic polymorphism (--174 G/C) within the interleukin-6 (IL-6) promoter reportedly has functional importance through the modulation of IL-6 expression in vitro and in vivo.
8083. Self-efficacy and health status in rheumatoid arthritis: a two-year longitudinal observational study.
To investigate the relationship between baseline level of self-efficacy for pain and other symptoms and changes in measures for similar dimensions of health status over a period of 2 yr in patients with rheumatoid arthritis (RA).
8084. Arthroscopic subacromial surgery in inflammatory arthritis of the shoulder.
To evaluate the effectiveness of shoulder arthroscopy, with predominantly subacromial surgery, in patients with inflammatory arthritis.
8085. Amelioration of rat antigen-induced arthritis by liposomally conjugated methotrexate is accompanied by down-regulation of cytokine mRNA expression.
作者: A S Williams.;N Topley.;S Dojcinov.;P J Richards.;B D Williams.
来源: Rheumatology (Oxford). 2001年40卷4期375-83页
We examined the temporal changes in the expression of interleukin 1beta (IL-1beta), tumour necrosis factor alpha (TNF-alpha) and interleukin 6 (IL-6) in the rat antigen-induced arthritis (AIA) model and investigated how their expression was modulated following disease amelioration by liposomally conjugated methotrexate (G-MLV).
8086. Treatment-induced remission in rheumatoid arthritis patients is characterized by a reduction in macrophage content of synovial biopsies.
作者: M D Smith.;M C Kraan.;J Slavotinek.;V Au.;H Weedon.;A Parker.;M Coleman.;P J Roberts-Thomson.;M J Ahern.
来源: Rheumatology (Oxford). 2001年40卷4期367-74页
To document the change in synovial membrane macrophage and T-lymphocyte content in rheumatoid arthritis (RA) patients who achieve remission induced by disease-modifying anti-rheumatic drugs (DMARDs).
8095. Pyrexia and normal C-reactive protein (CRP) in patients with systemic lupus erythematosus: always consider the possibility of infection in febrile patients with systemic lupus erythematosus regardless of CRP levels.8096. Fibromyalgia-monotheories, monotherapies and reductionism. |